Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Altesa BioSciences: The company raised $75 million Series B venture funding in a deal led by Forbion on February 19, 2026, putting the company’s pre-money valuation at $115...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Garner: The company raised $118 million of Series D venture funding in a deal led by Kleiner Perkins on February 10, 2026, putting the company’s pre-money valuation at $1.23...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Third Arc Bio: The company raised $217 million of Series A venture funding in a deal led by Cormorant Asset Management, Hillhouse Investment Group and Andreessen Horowitz on February...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Seamless Therapeutics: The company raised $1.1 billion of venture funding from Eli Lilly on January 30, 2026. The company is a developer of a gene editing technology used to enable...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions OpenEvidence: The company raised $250 million of Series D venture funding in a deal led by Thrive Capital and DST Global on January 21, 2026, putting the company’s pre-money...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Inquis Medical: The company raised $75 million of Series C venture funding from undisclosed investors on January 12, 2026, putting the company’s pre-money valuation at $300...
